JPH0231693B2 - - Google Patents

Info

Publication number
JPH0231693B2
JPH0231693B2 JP57113339A JP11333982A JPH0231693B2 JP H0231693 B2 JPH0231693 B2 JP H0231693B2 JP 57113339 A JP57113339 A JP 57113339A JP 11333982 A JP11333982 A JP 11333982A JP H0231693 B2 JPH0231693 B2 JP H0231693B2
Authority
JP
Japan
Prior art keywords
insulin
drug
chymotrypsin inhibitor
formula
blood sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57113339A
Other languages
English (en)
Japanese (ja)
Other versions
JPS595115A (ja
Inventor
Setsuo Fujii
Eizo Hatsutori
Mitsuteru Hirata
Koichiro Watanabe
Hiroshi Ishihama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP57113339A priority Critical patent/JPS595115A/ja
Priority to EP82303902A priority patent/EP0071433A1/en
Priority to CA000408188A priority patent/CA1174597A/en
Priority to DK334282A priority patent/DK334282A/da
Priority to AU86503/82A priority patent/AU8650382A/en
Publication of JPS595115A publication Critical patent/JPS595115A/ja
Publication of JPH0231693B2 publication Critical patent/JPH0231693B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57113339A 1981-07-28 1982-06-30 糖尿病治療用薬剤 Granted JPS595115A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP57113339A JPS595115A (ja) 1982-06-30 1982-06-30 糖尿病治療用薬剤
EP82303902A EP0071433A1 (en) 1981-07-28 1982-07-23 Medicine for the treatment of diabetes
CA000408188A CA1174597A (en) 1981-07-28 1982-07-27 Medicine for the treatment of diabetes
DK334282A DK334282A (da) 1981-07-28 1982-07-27 Medicinsk komposition samt fremgangsmaade og middel til dens fremstilling
AU86503/82A AU8650382A (en) 1981-07-28 1982-07-28 Synthetic phenyl ester chymotrypsin inhibitor to treat diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57113339A JPS595115A (ja) 1982-06-30 1982-06-30 糖尿病治療用薬剤

Publications (2)

Publication Number Publication Date
JPS595115A JPS595115A (ja) 1984-01-12
JPH0231693B2 true JPH0231693B2 (enrdf_load_stackoverflow) 1990-07-16

Family

ID=14609733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57113339A Granted JPS595115A (ja) 1981-07-28 1982-06-30 糖尿病治療用薬剤

Country Status (1)

Country Link
JP (1) JPS595115A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222484A (ja) * 1983-06-02 1984-12-14 Kowa Co テトラヒドロナフチルカルボン酸フエニルエステル誘導体
JPS6253954A (ja) 1985-09-02 1987-03-09 Ajinomoto Co Inc フエニルアラニン誘導体およびその用途
EP2725016B1 (en) * 2011-06-07 2016-12-21 EA Pharma Co., Ltd. Heterocyclic carboxylic acid ester derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5315412A (en) * 1976-07-27 1978-02-13 Ono Pharmaceut Co Ltd Suppository for diabetics
JPS55149240A (en) * 1979-05-09 1980-11-20 Kowa Co Hydroxybenzoic acid derivative and its acid addition salt
JPS56158737A (en) * 1980-05-07 1981-12-07 Kowa Co Phenyl ester

Also Published As

Publication number Publication date
JPS595115A (ja) 1984-01-12

Similar Documents

Publication Publication Date Title
JPS63258841A (ja) チロシン誘導体及びその用途
US4528291A (en) 2-(4'-Pyridinyl)-thiazole compounds and their use in increasing cardiac contractility
US4161595A (en) Levulinic acid salt
JP5425219B2 (ja) アミドチアゾール誘導体、その製造方法および使用
JPH05506854A (ja) 局部活性眼用チアジアゾールスルホンアミドカルボニックアンヒドラーゼ抑制剤
JPH0651625B2 (ja) 高脂質血症治療剤
JPS60158197A (ja) 抗生物質およびその製法
SU1212325A3 (ru) Способ получени производных бензопирана
JPH01190688A (ja) ピロリチジン化合物およびその用途
KR20070058381A (ko) 염증성 질환 치료용 페녹시알킬카르복실 산 유도체
EP0273375A2 (en) Propiophenone derivatives for treatment of pollakiuria (frequency urination)
JPH0231693B2 (enrdf_load_stackoverflow)
US3809754A (en) Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
CN101550112A (zh) 4,5-二取代噻唑衍生物、其制备方法和用途
CN100513415C (zh) 胆汁酸衍生物及其医药用途
CN111417632B (zh) 噻唑-5-甲酸衍生物及其制备方法与应用
DE69916571T2 (de) Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung
US4820718A (en) N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts and use thereof in PAF inhibition
JPS5821622A (ja) 糖尿病治療用薬剤
PL96042B1 (pl) Sposob wytwarzania nowych aminopochodnych azydofenoli
CN102875567B (zh) 一类含哌嗪化合物、制备及用途
JPH0460584B2 (enrdf_load_stackoverflow)
SU869267A1 (ru) N-[4-(3,3-Диметилтриазено)-фенилсульфонил]-изовалериламид, про вл ющий противовоспалительное действие
KR20240049517A (ko) 퀴놀린 메르캅토아세테이트 설폰아미드 유도체, 중간체, 약학적 유도체 또는 제형 및 이의 제조 방법 및 용도
JPS59190926A (ja) 吸収性付与剤